Skip to main content

Advertisement

SpringerLink
Log in

Tryptophan metabolites and anemia in patients with diabetic kidney disease

  • Research Letter
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wee HN, Liu JJ, Ching J, Kovalik JP, Lim SC (2021) The kynurenine pathway in acute kidney injury and chronic kidney disease. Am J Nephrol 52(10–11):771–787. https://doi.org/10.1159/000519811

    Article  CAS  PubMed  Google Scholar 

  2. Debnath S, Velagapudi C, Redus L et al (2017) Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers. Int J Tryptophan Res. https://doi.org/10.1177/1178646917694600

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kawashima Y, Sanaka T, Sugino N, Takahashi M, Mizoguchi H (1987) Suppressive effect of quinolinic acid and hippuric acid on bone marrow erythroid growth and lymphocyte blast formation in uremia. Adv Exp Med Biol 223:69–72. https://doi.org/10.1007/978-1-4684-5445-1_9

    Article  CAS  PubMed  Google Scholar 

  4. Pawlak D, Koda M, Pawlak S, Wolczynski S, Buczko W (2003) Contribution of quinolinic acid in the development of anemia in renal insufficiency. Am J Physiol Renal Physiol 284(4):F693-700. https://doi.org/10.1152/ajprenal.00327.2002

    Article  CAS  PubMed  Google Scholar 

  5. Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I (2016) Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation. Exp Hematol 44(1):60–71. https://doi.org/10.1016/j.exphem.2015.08.010

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Mass spectrometry analyses were conducted at the Mass Spectrometry Core Facilities, University of Texas Health San Antonio, on instrumentation obtained with funding from the NIH (1S10OD016417-01). A.S. is supported by NIH/NCATS Grant TL1 TR002647.

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, MC 7882, University of Texas Health San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA

    Subrata Debnath, Afaf Saliba, Balakuntalam S. Kasinath & Kumar Sharma

  2. Department of Medicine, Dell School of Medicine, University of Texas at Austin, Austin, TX, USA

    Nimmy Thomas

  3. Division of Hospital Medicine, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA

    Saket Kottewar & Sheena Grant

  4. Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA

    Carlos Lorenzo

Authors
  1. Subrata Debnath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nimmy Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Afaf Saliba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saket Kottewar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sheena Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Balakuntalam S. Kasinath
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kumar Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carlos Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Subrata Debnath.

Ethics declarations

Author Contributions

SD and CL conceived the project, performed statistical analysis, and interpreted the results. SD reviewed the literature and drafted the manuscript. All authors (SD, NT, AS, SK, SG, BSK, KS, CL), reviewed the Manuscript and accepted the final version.

Funding

None.

Data availability

The datasets collected and analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of interest

The authors declare that they have no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethics approval

The study was undertaken in accordance with the Declaration of Helsinki (Institutional Review Board protocol # 20140210HU).

Informed consent

Written informed consent was obtained from all participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Debnath, S., Thomas, N., Saliba, A. et al. Tryptophan metabolites and anemia in patients with diabetic kidney disease. J Nephrol 36, 1083–1085 (2023). https://doi.org/10.1007/s40620-023-01620-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-023-01620-0

Keywords

Search

Navigation